FindTrial
Sign In

Terameprocol (EM-1421)

DRUG2 trials

Sponsors

Erimos Pharmaceuticals

Conditions

Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Adult T Cell Leukemia (ATL)Chronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia (CML-BP)Chronic Myelomonocytic Leukemia (CMML)LeukemiasLymphoma

Phase 1

A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
TerminatedNCT00664586
Erimos PharmaceuticalsLymphoma, Refractory Solid Tumors
Start: 2007-05-31End: 2009-06-30Updated: 2016-02-23
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
TerminatedNCT00664677
Erimos PharmaceuticalsAcute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Adult T Cell Leukemia (ATL) +5
Start: 2007-08-31End: 2009-06-30Updated: 2016-02-23